resistência de helmintos gastrintestinais de bovinos a anti-helmínticos no planalto catarinense anthelmintics resistance of bovine gastrointestinal helminths in santa catarina plateau
Clicks: 204
ID: 187652
2008
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
30.0
/100
204 views
32 readers
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #275 of 436 articles by views in Trials
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 436 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Com o objetivo de avaliar focos de resistência de helmintos gastrintestinais parasitos de bovinos, com aptidão para corte, à ivermectina, ao fosfato de levamisole e ao sulfóxido de albendazole foram realizadas avaliações em 39 propriedades localizadas no Planalto Catarinense. Em cada uma foram coletadas, em média, 60 amostras de fezes de animais, com idade entre sete e 18 meses, para avaliar o número de ovos por grama de fezes (OPG), o cultivo e a identificação de larvas. Foram formados três grupos de animais com média de OPG semelhante. A média de OPG de todos os animais coletados, antes do tratamento, foi considerada como testemunha. Cada grupo recebeu um tratamento diferente por via subcutânea (ivermectina na dose de 0,2mg kg-1, fosfato de levamisole na dose de 5mg kg-1 e sulfóxido de albendazole na dose de 2,5mg kg-1). Sete dias após foram repetidas as avaliações por grupo. Considerou-se resistência quando a eficácia da droga foi menor que 95% e o limite inferior do intervalo de confiança IC95% menor que 90%. Entre as propriedades avaliadas, 82,1% apresentaram animais com helmintos resistentes à ivermectina, 15,4% ao fosfato de levamisole e 7,8% ao sulfóxido de albendazole. Em apenas 10,3% das propriedades, a eficácia de todos os anti-helmínticos foi superior a 95%. Com base no diagnóstico genérico, verificou-se que os gêneros predominantes resistentes à ivermectina foram Cooperia spp e Haemonchus spp, ao fosfato de levamisole, Ostertagia spp, Cooperia spp e Trichostrongylus spp, e ao sulfóxido de albendazole, Cooperia spp.
In order to estimate possible focus of resistance of bovine gastrointestinal helminths to ivermectin, levamisole phosphate and albendazole sulphoxide, 39 properties in the Santa Catarina Plateau were evaluated. In each location a mean number of 60 samples of feces was collected from animals between seven and 18 months of age, for the evaluation of the number of eggs per gram of feces (EPG), for culture and for larvae identification. Three groups with similar EPG mean were comprised, with the mean EPG being considered the group control. Animal from each group received a different subcutaneous treatment: a) 0.2mg kg-1 ivermectin, b) 5mg kg-1 levamisole phosphate, and c) 2.5mg kg-1 albendazole sulphoxide). The fecal evaluation, per group, was repeated seven days later. Resistance was considered when the efficacy of the drug was lesser than 95% and when the inferior limit of the confidence interval CI95% was lesser than 90%. From the properties examined, 82.1% presented animals with helminths resistant to ivermectin, 15.4% to levamisole phosphate, and 7.8% to albendazole sulphoxide. In only 10.3% of the properties the efficacy of all the anthelmintics was superior to 95%. Based on the generic diagnosis, through the larvae identification, Cooperia spp and Haemonchus spp were the prevailing resistant genus to ivermectin, Ostertagia spp, Cooperia spp and Trichostrongylus spp were associated with resistance to levamisole phosphate, and Cooperia spp. to albendazole sulphoxide.
In order to estimate possible focus of resistance of bovine gastrointestinal helminths to ivermectin, levamisole phosphate and albendazole sulphoxide, 39 properties in the Santa Catarina Plateau were evaluated. In each location a mean number of 60 samples of feces was collected from animals between seven and 18 months of age, for the evaluation of the number of eggs per gram of feces (EPG), for culture and for larvae identification. Three groups with similar EPG mean were comprised, with the mean EPG being considered the group control. Animal from each group received a different subcutaneous treatment: a) 0.2mg kg-1 ivermectin, b) 5mg kg-1 levamisole phosphate, and c) 2.5mg kg-1 albendazole sulphoxide). The fecal evaluation, per group, was repeated seven days later. Resistance was considered when the efficacy of the drug was lesser than 95% and when the inferior limit of the confidence interval CI95% was lesser than 90%. From the properties examined, 82.1% presented animals with helminths resistant to ivermectin, 15.4% to levamisole phosphate, and 7.8% to albendazole sulphoxide. In only 10.3% of the properties the efficacy of all the anthelmintics was superior to 95%. Based on the generic diagnosis, through the larvae identification, Cooperia spp and Haemonchus spp were the prevailing resistant genus to ivermectin, Ostertagia spp, Cooperia spp and Trichostrongylus spp were associated with resistance to levamisole phosphate, and Cooperia spp. to albendazole sulphoxide.
| Reference Key |
souza2008cinciaresistncia
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;Antonio Pereira de Souza;César Itaqui Ramos;Valdomiro Bellato;Amélia Aparecida Sartor;Crisciane Aparecida Schelbauer |
| Journal | Trials |
| Year | 2008 |
| DOI |
10.1590/S0103-84782008000500026
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.